Browse the evidence

Lifestyle modifications (diet and physical activity) produce 5-10% weight loss and improve metabolic health, serving as the recommended first-line therapy for obesity.

Adopt a sustainable diet that creates a caloric deficit and engage in regular physical activity, including both aerobic exercise and strength training. This approach reliably yields 5-10% body weight loss and improves metabolic health markers like blood pressure and HbA1c. Consistency and realistic goal-setting are key to long-term success.

Time-restricted feeding (4-8 hour eating window) without caloric restriction significantly reduces body weight and fat mass compared to ad-libitum control diets in overweight or obese adults.

To lose weight using time-restricted feeding, choose a daily window of 4 to 8 hours for all your meals (e.g., 12 PM to 8 PM). Eat normally within this window without counting calories. Maintain this schedule for at least 8 weeks. You can expect to lose approximately 2 kg more than if you ate whenever you wanted, along with a reduction in body fat.

Time-restricted eating (TRE) significantly reduces body weight, fat mass, BMI, and waist circumference in adults, but does not significantly reduce fat mass percentage.

If you are an adult looking to lose weight and body fat, restricting your daily eating window to 12-20 hours (fasting for 4-12 hours) is an effective strategy. You can expect significant reductions in body weight, waist circumference, and fat mass. However, be aware that this method also leads to a loss of fat-free mass (muscle) and does not significantly change your body fat percentage. It is not necessarily superior to standard calorie restriction for weight loss, but may be easier to adhere to for some people.

Reducing total caloric intake by 500-1,000 kcal daily (Low-Calorie Diet) is a safe, practical, and effective primary strategy for obesity management, yielding 0.5-1.0 kg weight loss per week.

To lose weight safely, reduce your daily calories by 500 to 1,000 compared to what you normally eat. This simple deficit typically results in losing 0.5 to 1.0 kg per week and is considered safe for most people without strict medical supervision.

Intermittent fasting (16:8 time-restricted eating) produces significantly greater weight loss and improvements in fasting glucose and triglycerides compared to standard calorie restriction in obese adults over an 8-week period.

If you are obese and struggling with weight loss, try a 16:8 intermittent fasting schedule (eat within an 8-hour window, fast for 16) for at least 8 weeks. This approach may yield better weight loss and metabolic improvements than simply counting calories, and it is generally well-tolerated.

Obesity is positively correlated with increased prevalence of cardiovascular disease in Type 2 Diabetes, with heart failure prevalence increasing by 65% in obese patients (BMI ≥ 30) compared to non-obese patients.

Maintaining a healthy weight is crucial for heart health in Type 2 Diabetes. Obese patients (BMI ≥ 30) have a 65% higher prevalence of heart failure compared to non-obese patients. Weight management through diet and exercise can significantly reduce this specific cardiovascular risk.

Administration of specific probiotic strains (e.g., L. gasseri SBT2055, L. plantarum) for 6-12 weeks significantly reduces body mass index (BMI), waist circumference, and visceral fat area in overweight or obese adults.

If you are overweight, try adding a probiotic containing L. gasseri SBT2055 or L. plantarum to your daily routine for at least 12 weeks. This is not a magic bullet, but studies show it can help reduce belly fat and BMI when combined with your normal diet. It works best when you choose the specific strains mentioned in research.

Weight loss of up to 16% of original body weight is sufficient to improve beta-cell function and insulin sensitivity in adipose tissue, liver, and skeletal muscle by correcting dysregulated gene expression related to lipid and oxidative stress.

Losing up to 16% of your body weight through gradual lifestyle changes (diet and exercise) can significantly improve your body's sensitivity to insulin and improve beta-cell function. This reduction in weight helps reverse the metabolic dysfunction associated with obesity.

Weight loss is the primary therapy for NAFLD, improving liver biochemistry, histology, and insulin sensitivity.

Lose weight through diet and exercise. This is the most effective way to improve liver health in NAFLD patients, even without medication.

Bariatric and metabolic surgery leads to resolution of NAFLD/NASH in the majority of patients and regression of liver fibrosis.

For eligible patients, bariatric surgery is a highly effective treatment that can resolve NAFLD and reverse liver fibrosis.

Creatine supplementation reduces the incidence of musculoskeletal injuries, dehydration, and muscle cramping in athletes during training and competition.

If you are a team sport athlete, taking creatine may help you stay healthier by reducing cramps and injuries. It is safe and well-tolerated.

Habitual consumption of sugar-sweetened beverages (SSBs) causes weight gain and increases the risk of type 2 diabetes, cardiovascular disease, and all-cause mortality.

To prevent age-related weight gain and reduce chronic disease risk, limit or eliminate sugar-sweetened beverages. Replacing SSBs with non-caloric options (water, unsweetened tea/coffee) has been shown to reduce body weight, particularly in individuals with overweight or obesity. Be aware that liquid calories from soda do not make you feel full, so you are likely to consume these calories on top of your normal food intake.

Replacing SSBs with non-caloric beverages reduces body weight and BMI gain, especially in children and individuals with overweight or obesity.

If you want to lose weight or prevent weight gain, swap your sugary drinks for water or unsweetened alternatives. This is particularly effective if you have excess weight. You do not need to eliminate all sugar from your diet, but removing liquid sugar is one of the most impactful single changes you can make.

Gradual weight reduction through diet, with or without exercise, improves serum liver enzymes, reduces hepatic fatty infiltration, decreases hepatic inflammation, and reduces fibrosis levels in NAFLD patients.

Focus on gradual weight loss through dietary changes and/or exercise. You do not need to achieve extreme weight loss or intense exercise levels to see benefits; even minimal exercise below obesity management recommendations can improve hepatic fatty infiltration. This approach addresses the root metabolic drivers of NAFLD.

Caloric restriction and exercise training can reverse metabolic inflexibility by enhancing mitochondrial function and promoting the expression of key metabolic regulators like PGC1α and AMPK.

Regular exercise and controlled caloric intake are proven ways to improve your body's metabolic flexibility. Exercise triggers signals (like AMPK and PGC1α) that boost mitochondrial function and insulin sensitivity. Consistent application of these lifestyle factors can help reverse metabolic inflexibility associated with obesity and type 2 diabetes.

Physical activity reduces type 2 diabetes risk by approximately 30% compared to low activity levels, primarily through improved insulin sensitivity and visceral fat reduction rather than total calorie expenditure.

Increase your total physical activity, specifically by reallocating 30 minutes of sedentary time (like watching TV or sitting at a desk) into moderate to vigorous movement. This specific change improves insulin sensitivity by 15% and reduces diabetes risk by 30%, independent of significant weight loss.

Replacing sitting time with vigorous physical activity (VPA) yields the largest reduction in cardiovascular disease mortality risk, particularly for individuals who sit more than 6 hours per day.

If you sit for more than 6 hours a day, try to replace some of that time with vigorous exercise (like running, fast cycling, or high-intensity interval training). This substitution offers the greatest protection against heart disease-related death. Even replacing sitting with brisk walking helps, but vigorous activity provides the strongest benefit for high sitters.

Weight loss of 7-10% is the primary therapeutic target for NAFLD, as it resolves NASH in 65-90% of patients and improves fibrosis in 45% of patients.

To reverse fatty liver disease (NASH), you need to lose 7-10% of your body weight. Losing just 3-5% helps reduce liver fat, but you need the higher 7-10% range to resolve the inflammation and scarring. Focus on a Mediterranean-style diet and avoid snacking to achieve a steady loss of 0.5-1 kg per week.

Physical activity follows a dose-response relationship where even modest levels of activity are superior to being sedentary, reducing all-cause mortality risk.

Do not wait for the 'perfect' workout. Any amount of physical activity, even modest, reduces your risk of death compared to being sedentary. Start small.

Intermittent fasting significantly reduces body weight, waist circumference, fat mass, BMI, systolic and diastolic blood pressure, total cholesterol, triglycerides, fasting blood glucose, fasting insulin, and insulin resistance (HOMA-IR) compared to control diets.

Intermittent fasting is an effective strategy for improving multiple cardiometabolic risk factors, including weight, blood pressure, and blood sugar control, compared to standard diets. However, it does not significantly improve HbA1c, LDL, or HDL cholesterol. To maximize benefits, choose a fasting protocol (like 16:8 or 5:2) that you can sustain, ensure you are not overeating during feeding windows to avoid muscle loss, and consult a healthcare provider, especially if you have existing health conditions.

Achieving a modest weight loss of 5–10% of initial body weight is sufficient to obtain substantial health benefits and decrease comorbidities, making this a primary treatment goal rather than maximum weight loss.

Set a realistic goal of losing 5–10% of your current body weight. This modest amount is clinically proven to significantly reduce health risks like diabetes and heart disease. Focus on sustainable lifestyle changes rather than rapid, extreme weight loss, which often leads to regaining the weight.

Reducing waist circumference is a more important clinical indicator than weight loss per se because it directly correlates with decreased visceral fat and associated cardiometabolic risks.

Measure your waist circumference regularly in addition to weighing yourself. A reduction in waist size is a stronger indicator of improved health and reduced heart disease risk than weight loss alone, as it reflects the loss of dangerous visceral fat.

Lifestyle modification focusing on weight loss and exercise is the primary effective therapy for reversing features of non-alcoholic steatohepatitis (NASH) and fibrosis.

Focus on sustainable weight loss and regular physical activity. Adopting a Mediterranean-style diet and increasing exercise are the most proven ways to reverse liver inflammation and fibrosis in NAFLD patients. This is the first-line treatment before considering medications.

Beta-alanine is a more effective precursor than histidine for increasing muscle carnosine content and reducing fatigue during high-intensity exercise.

If your goal is to improve high-intensity exercise performance by increasing muscle carnosine, take beta-alanine (4.8–6.4 g/day) for at least 4 weeks. Taking histidine is less effective for this specific purpose.